Account
dentsu X bags media mandate of Roca Parryware
MUMBAI: dentsu X has won the media account for Roca Bathroom Products, also known as Roca Parryware. The agency will oversee media strategy, planning, and buying for the entire portfolio of both brands, Roca and Parryware. The account was won following a multi-agency pitch.
Roca Parryware managing director KE Ranganathan said, “Our company is back to healthy double digit revenue growth since October 2020. Looking into the year ahead, there is huge optimism to sustain and grow even higher. To drive this growth momentum we are embarking on a focused brand campaign through mass media for our power brands – Roca and Parryware. While these two brands enjoy high brand recall among our customers, it is important for us to continue to stay on top-of-the-mind and embed relevant brand attributes. With this agenda we looked towards dentsu X for a solution. We were impressed by their understanding of our target audience and the bathroom space. Their proprietary tools and strategy will help us optimise each platform and enhance our reach. We are excited to work with dentsu X and develop innovative new media plans.”
dentsu X chief executive officer Divya Karani added, “We are delighted to be the strategic media partners to Roca Parryware. We look forward to partnering them in scaling new heights.”
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
